id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6580-48871,FDA,FDA-2017-D-6580,Homeopathic Drug Products; Guidance for FDA Staff and Industry,Other,Guidance,2022-12-07T05:00:00Z,2022,12,2022-12-07T05:00:00Z,,2026-01-10T12:25:39Z,,1,0,0900006485521d8e
FDA-2017-D-6580-48870,FDA,FDA-2017-D-6580,Homeopathic Drug Products; Guidance for Food and Drug Administration Staff and Industry; Availability - Final Guidance,Notice,Notice of Availability,2022-12-07T05:00:00Z,2022,12,2022-12-07T05:00:00Z,,2022-12-07T15:57:13Z,2022-26567,0,0,09000064855212ae